I understand your 'point in time' analysis and take. I would agree that when it reported EPS, as they are also point in time snapshots, then yes the fully diluted count is 835M.
However, I think we just have a difference of opinion as to when the preferred to common conversion would take place and the count of common shares available at that time. Of course I'm taking a more optimistic view on the firm, I'm a long and I'm hoping they succeed as a firm.
You make a point on understanding the entire structure of the firm, which I have done my best to do. Their preferred share conversion structure is not normal. Their options, warrants, and debts - to date - have not been favorable. The strikes and conversion prices for many of these debts have been in the sub penny range. However, many of those, as you so pointed out - have already converted and those debts are already baked in.
The remaining toxic debt, is currently in litigation. One of those debts has the potential to again, radically alter their share structure, based on it's size and convertible price. That said, I still remain optimistic that POTN receives a favorable judgement
POTN has a fantastic market position and produces a great product within an infant industry. As they continue to grow and mature as a firm, these items which we are discussing will continue to get ironed out. It hasn't been perfect to date, but I hope that continues to get better.
Let's not forget this is an OTC stock and does not come without it's fair share of risk. Personally, I feel the risk is still worth the potential reward.
